Table 1

Country and physician characteristics, values are reported as means with SD, unless otherwise stated (complete case data)

BelgiumFranceGermanyIrelandItalyNLSwedenUK
Number of physicians7378382720586254
Age (years)53.2 (12.0)51.2 (8.7)50.4 (9.1)49.5 (8.5)53.4 (5.3)49.7 (7.9)53.6 (9.2)47.1 (8.6)
Percentage primary care97.3%89.7%92.1%25.9%50.0%100%100%77.8%
Number of patients per week (median, IQR)100 (58)120 (49)275 (150)90 (100)100 (70)112.5 (59)50 (22)120 (80)
Percentage T2DM of patients per week (median, IQR)6.7 (9.5)6.3 (6.1)17.5 (20.7)55.0 (57.9)33.3 (59.2)6.2 (6.0)7.2 (5.1)16.2 (26.8)
Percentage of physicians suggesting patients to follow diabetes education (yes/no)74.0%75.3%42.1%96.3%50.0%96.6%95.2%100%
Percentage physicians aware of T2DM guidelines (yes/no)84.7%93.4%83.8%96.3%95.0%98.3%95.2%100%
Attitude towards T2DM guidelines score (17-85)62 (11)64 (9)56 (10)66 (9)67 (8)69 (6)65 (9)63 (6)
Target HbA1c in guideline according to physician (mmol/mol)50.5 (4.2)48.6 (3.3)48.5 (3.3)49.8 (3.2)51.7 (1.9)52.2 (3.0)49.4 (4.1)51.1 (2.8)
Target HbA1c in national guidelines valid in 2009 (mmol/mol)*<53<48≤48<4848–53<53<48<48†
Target HbA1c in most recent national guidelines (mmol/mol)‡48–6448–7548–5848–5848–6453–6442–6948–53
  • *Glycaemic targets were extracted from reference.34

  • †Higher for individual patients.

  • ‡Glycaemic targets were extracted from national guidelines from primary care for each country.

  • HbA1c, glycated haemoglobin; NL, the Netherlands; T2DM, type 2 diabetes mellitus; UK, United Kingdom.